Harry J. Leonhardt

2021 - Poseida Therapeutics

In 2021, Harry J. Leonhardt earned a total compensation of $1.4M as General Counsel, Chief Compliance Officer and Corporate Secretary at Poseida Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$149,580
Option Awards$867,018
Salary$415,500
Other$9,252
Total$1,441,350

Leonhardt received $867K in option awards, accounting for 60% of the total pay in 2021.

Leonhardt also received $149.6K in non-equity incentive plan, $415.5K in salary and $9.3K in other compensation.

Rankings

In 2021, Harry J. Leonhardt's compensation ranked 7,413th out of 12,412 executives tracked by ExecPay. In other words, Leonhardt earned more than 40.3% of executives.

ClassificationRankingPercentile
All
7,413
out of 12,412
40th
Division
Manufacturing
3,258
out of 5,498
41st
Major group
Chemicals And Allied Products
1,441
out of 2,374
39th
Industry group
Drugs
1,284
out of 2,095
39th
Industry
Biological Products, Except Diagnostic Substances
297
out of 452
34th
Source: SEC filing on April 26, 2023.

Leonhardt's colleagues

We found three more compensation records of executives who worked with Harry J. Leonhardt at Poseida Therapeutics in 2021.

2021

Eric Ostertag

Poseida Therapeutics

Chief Executive Officer

2021

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2021

Matthew Spear

Poseida Therapeutics

Chief Medical Officer

News

In-depth

You may also like